news
Modified gut bacteria shrink tumors, boost immune response
Scientists developed engineered *E. coli* bacteria that can be injected directly into tumors to release anti-cancer drugs locally, shrinking tumors in mice. Published in *Nature*, the work by researchers like Tal Danino at Columbia University shows these bacteria also stimulate the immune system, acting as a living drug delivery system.
Scientists developed engineered E. coli bacteria that can be injected directly into tumors to release anti-cancer drugs locally, shrinking tumors in mice. Published in Nature, the work by researchers like Tal Danino at Columbia University shows these bacteria also stimulate the immune system, acting as a living drug delivery system.
The architecture take
Okay, so direct tumor injection with engineered E. coli sounds like something out of a sci-fi movie, but the mechanism here is seriously clever. Instead of blasting the whole system with chemo, they're sending bacteria straight to the tumor. These bacteria then act like tiny factories, churning out immunotherapy drugs right where they're needed most. It means fewer systemic side effects, which is a massive win for the body's overall load and recovery capacity. What's wild is that the bacteria also kick the immune system into gear, helping it recognize and fight the cancer cells. This isn't just about localized drug delivery; it's a way to wake up the body's own defenses from the inside. I'm watching this. It could fundamentally change how we think about targeted therapies, moving away from broad-spectrum attacks toward precision strikes that don't exhaust the whole system. The gut microbiome's role in immunity was already clear, but this is next-level.